| Name | Title | Contact Details |
|---|
ContraVir is a biopharmaceutical company focused primarily on the development of drugs to treat herpes zoster, or shingles, which is an infection caused by the reactivation of varicella zoster virus or VZV. Our lead candidate, FV-100, is an orally available nucleoside analogue prodrug of CF-1743 that we are developing for the treatment of shingles. Published preclinical studies demonstrate that FV-100 is significantly more potent against VZV than acyclovir, valacyclovir, and famciclovir, the FDA-approved drugs used for the treatment of shingles. Preclinical studies further demonstrate that FV-100 has a more rapid onset of antiviral activity, and may fully inhibit the replication of VZV more rapidly than these drugs at significantly lower concentration levels. In addition, pharmacokinetic data from completed phase 1 and 2 clinical trials suggest that FV-100 has the potential to demonstrate antiviral activity when dosed orally once-a-day at significantly lower levels than valacyclovir, acyclovir, and famciclovir.
As one of the largest and fastest-growing Emergency and Hospital Medicine groups in the nation, we partner with more than 5,000 world-class providers who treat more than 6 million patients annually. Physician-led, our team consists of motivated, personable, highly qualified people interested in putting the patient first. We’re committed to doing the right thing for the patients, physicians, and hospitals we serve. Which is why 98% of our physicians recommend us to colleagues and friends. William C. Schumacher, M.D., a board certified emergency medicine physician, formally founded the Schumacher Group in 1994. The philosophy behind Schumacher Group`s founding was based on his belief that there was a better way to deliver and manage emergency medical services in the hospital environment. That `better way` is embodied in our founding mission. The Schumacher Group became known as Schumacher Clinical Partners in 2016.
Caliola Engineering is a woman-owned small business that provides systems, security, and software engineering services to the US Government. They specialize in wireless communications, cryptography, protected MILSATCOM, software defined radio, and unma...
Omnibus Health is a New York, NY-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Privis Health is a leading provider of innovative data-driven population health programs and technology rich services that enable healthcare providers to deliver high quality efficient care to their patient population. Our scalable, cloud-based platform empowers healthcare providers to better manage risk, while achieving their operating and performance goals as they transition from fee-for-service to value based reimbursement. In addition, we assist with the design, implementation and expansion of population health programs, while sharing in the accountability for the success of these initiatives. The Privis team has deep experience with a programmatic approach to provide strategies on service models, organizational transformation, quality improvements and learning health system activities. Offerings include care management, care coordination, transitions of care, chronic care management, and complex CCM programs working in tandem with patient engagement and placement services. We provide a tool kit of evidence-based chronic disease and socio-behavioral assessments that drive the creation of a dynamic shared care plan. Our gaps-in-care offering captures important variances in care, such as preventive care, community resources, and guides interventions to assist the patient in achieving better outcomes and appropriate interventions